Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.
Accurately determining a company’s long-term prospects isn’t easy, especially when sentiment is weak. That’s where StockStory comes in - to help you find attractive investment candidates backed by unbiased research. That said, here is one stock where Wall Street’s pessimism is creating a buying opportunity and two where the skepticism is well-placed.
Two Stocks to Sell:
Richardson Electronics (RELL)
Consensus Price Target: $12 (-3.2% implied return)
Founded in 1947, Richardson Electronics (NASDAQ: RELL) is a distributor of power grid and microwave tubes as well as consumables related to those products.
Why Should You Dump RELL?
- Backlog has dropped by 3.4% on average over the past two years, suggesting it’s losing orders as competition picks up
- Lacking free cash flow generation means it has few chances to reinvest for growth, repurchase shares, or distribute capital
- Diminishing returns on capital from an already low starting point show that neither management’s prior nor current bets are going as planned
At $12.40 per share, Richardson Electronics trades at 37.6x forward P/E. To fully understand why you should be careful with RELL, check out our full research report (it’s free).
Hologic (HOLX)
Consensus Price Target: $76.60 (1.3% implied return)
As a pioneer in 3D mammography technology that has revolutionized breast cancer detection, Hologic (NASDAQ: HOLX) develops and manufactures diagnostic products, medical imaging systems, and surgical devices focused primarily on women's health and wellness.
Why Do We Steer Clear of HOLX?
- Underwhelming constant currency revenue performance over the past two years suggests its product offering at current prices doesn’t resonate with customers
- Adjusted operating margin declined by 17.7 percentage points over the last five years as its sales cratered
- Sales were less profitable over the last five years as its earnings per share fell by 7.3% annually, worse than its revenue declines
Hologic’s stock price of $75.60 implies a valuation ratio of 16.7x forward P/E. Dive into our free research report to see why there are better opportunities than HOLX.
One Stock to Buy:
OSI Systems (OSIS)
Consensus Price Target: $300 (4.1% implied return)
With security scanners deployed at airports and borders worldwide and patient monitors used in hospitals across the globe, OSI Systems (NASDAQ: OSIS) designs and manufactures specialized electronic systems for security screening, patient monitoring, and optoelectronic applications.
Why Is OSIS a Top Pick?
- Annual revenue growth of 14.7% over the past two years was outstanding, reflecting market share gains this cycle
- Share repurchases over the last five years enabled its annual earnings per share growth of 14.9% to outpace its revenue gains
- Free cash flow margin expanded by 4.5 percentage points over the last five years, providing additional flexibility for investments and share buybacks/dividends
OSI Systems is trading at $288.32 per share, or 26.1x forward P/E. Is now the time to initiate a position? Find out in our full research report, it’s free.
Stocks We Like Even More
ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren't just high-quality businesses. Something is happening with them right now. Elite fundamentals meeting near-term momentum — both boxes checked at the same time.
Find out which stocks our AI platform is flagging this week. See this week's Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.
